XML 41 R32.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY (DEFICIT) (Tables)
3 Months Ended
Mar. 31, 2022
Equity [Abstract]  
SUMMARY OF WARRANTS ACTIVITY

A summary of the Company’s stock warrants activity is as follows:

   Number of Options (in thousands)  

Weighted-

Average Exercise Price

  

Weighted-

Average Contractual Term
(in years)

   Aggregate Intrinsic Value 
Outstanding at December 31, 2021   165,077   $2.05    

4.9

    - 
Granted   -    

-

           
Exercised   -    -           
Canceled   -    -           
Outstanding at March 31, 2022   165,077   $2.05    4.6   $- 
Vested and expected to vest at December 31, 2021   165,077   $2.05    4.6   $- 
Exercisable at March 31, 2022   165,077   $2.05    4.6   $- 
SCHEDULE OF FAIR VALUE OF STOCK OPTIONS GRANTED ASSUMPTIONS

The fair values of warrants granted in 2021 were estimated using the Black-Scholes option pricing model on the grant date using the following assumptions:

 

   March 31, 
   2022 
Weighted-average grant date fair value per share  $8.14 
Risk-free interest rate   0.76% - 0.84%
Dividend yield   %
Expected term (in years)   5 
Volatility   368 - 369%